AXL and non-small cell lung carcinoma: AXL is a receptor tyrosine kinase of the TAM family that has become an important factor influencing the resistance of NSCLC and other cancers to chemotherapy, radiotherapy, and targeted therapy because of its key role in mediating EMT and immune evasion (153, 154).